- Additional Authors
- Center for Biologics Evaluation and Research (U.S.)
- Description
- 30 pages : digital, PDF file
- Alternative Title
- Biological product deviation reporting for blood and plasma establishments
- Subject
- Blood banks > Government policy > United States
- Note
- Title from PDF title page (viewed on May 14, 2009).
- "October 2006".
- Bibliography (note)
- Includes bibliographical references (page 30).
- System Details (note)
- Mode of access: Internet at the FDA CBER web site. Address as of 5/14/09: http://www.fda.gov/cber/gdlns/devbld.pdf ; current access is available via PURL.
- Call Number
- GPO Internet HE 20.4802:B 52/3
- OCLC
- marcive320959242
- Title
Guidance for industry : biological product deviation reporting for blood and plasma establishments.
- Publisher
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006]
- Type of Content
text
- Type of Medium
computer
- Type of Carrier
online resource
- System Details
Mode of access: Internet at the FDA CBER web site. Address as of 5/14/09: http://www.fda.gov/cber/gdlns/devbld.pdf ; current access is available via PURL.
- Bibliography
Includes bibliographical references (page 30).
- Connect to:
- Added Author
Center for Biologics Evaluation and Research (U.S.)
- Gpo Item No.
0499-T-02 (online)
- Sudoc No.
HE 20.4802:B 52/3